BIRAC GCI — Screening & Diagnosis Innovations Open Call — Eligibility Criteria

Indian academic and research institutions, public and private R&D organisations, start-ups incorporated in India, and not-for-profit foundations are all eligible. Multidisciplinary consortia that include academic, clinical, and industry partners are especially encouraged. Proposals must target screening or diagnostics for tuberculosis, emerging pathogens, syndromic panels, or enteric pathogens. Innovations should ideally be near point-of-care and ultra-low-cost with a high-risk, high-reward profile. Prior DPIIT registration or MSME certification is not required.

BIRAC GCI — Screening & Diagnosis Innovations Open Call is open to startups at the idea, product and revenue stage working in health pharma biotech. It is open to startups registered anywhere in India. Applicants should be registered as private limited, llp and partnership.